There is a general agreement that cancer development in humans as well as in animals in many organs or tissues involves a stepwise process in which new cell populations are regularly seen (9, 10). This overall pattern is seen with different types of carcinogenic stimuli including chemicals, radiations, and some viruses and in cancer development without any known etiologic agents such as in the colon and breast in humans. Some of these new cell populations function as sites of yet another new or aItered noncancerous cell population. With each step, the process shows an increased probability of evolving ultimately into a malignant neoplastic population that, in turn, continues to show this progression until death of the cancer cells or of their host.
It is also becoming evident that each of the phenotypic landmarks of malignancy such as (a) relatively autonomous growth, (b) invasion, and (c) metastasis occur quite late in the whole process of carcinogenesis and appear to be acquired seriatum and not as a single "package." In humans, judging by the evidence in lung, colon, uterus, skin, liver, thyroid, and some other sites, the process often takes 10, 20, or 30 yr before the manifestations of malignancy appear. This is comparable to the one-third to two-thirds of the normal life span often required in experimental animals for the same process to unfold.
BIOLOGIC PATTERNS OF CANCER
DEVELOPMENT .
There appear to be at least three patterns of development of cancer in humans and in experimental animals.
Cancer Development with Discrete Focal
Presented at thc Third lnlernalional Symposium of thc Socicty of Toxicologic I'athologisls. hlay 13-15, 1984. Arlington. \'A.
Proliferations as "Precancerous"
Steps. This appears to be the most common pattern by far for cancer development in many organs or tissues. Also this is the pattern most frequently used for the study of carcinogenesis in experimental animals. Papillomas in the skin and urinary tract system including the urinary bladder, polyps ("adenomatous polyps" or "adenomas") in the colon, stomach, and other sites in the gastrointestinal tract, and nodules in the liver, pancreas, thyroid, kidney, and other solid organs are common examples in which focal collections of expanded initiated cells, often designated uncritically as benign neoplasms, are important components of the system. Their delineation as "benign neoplasms" is operationally useful especially for surgeons and other practitioners, but it is difficult to defend scientifically in many instances. To date, these systems are the most amenable to scientific analysis, since their occurrence makes it possible to pose hypotheses concerning possible precancerous steps and to devise appropriate experimental tests. They remain the only systems that can be critically studied with respect to possible cellular, biochemic, and genetic events in the carcinogenic process, since they offer a cellular biologic focus.
Cancer Development without Obvious Focal Discrete Proliferations. It has been stated on occasion that cancer in the skin, liver, and possibly elsewhere can occur and perhaps even frequently occurs without the obligatory presence of intermediate focal proliferations, papillomas, or nodules. This perception appears to be particularly common in the skin when cancer develops with long term exposure to active carcinogens.
This pattern has yet to be developed for study. In addition to the skin, one of the most common human examples is the uterine cervix in which exophytic or projecting lesions are not seen regularly during the long precancerous period of cancer development. However, in these systems, microscopic focal proliferations of basal cells with obvious disturbances in squamous differentiation are regularly seen during the prolonged periods of atypical hyperplasia and carcinoma in situ.
Cancer Development without Precursor or Precancerous Lesions. Are precancerous lesions obligatory for cancer development? There is no current answer to this question. With chemicals, radiations, and many viruses, as well as with dietary deficiencies such as of choline, cancer development directly from adult or even young cells has never been established either in vivo or in vitro. Even in the in vitro systems, malignant transformation involves many cell cycles and functional and cellular alterations as putative precursors.
There are, however, a few apparent exceptions. In in vitro transformation with Rous sarcoma virus and perhaps a few other retroviruses, malignant transformation can be seen within one cycle of celI proliferation. In vivo, Rous sarcoma virus can induce sarcoma very rapidly in chickens.
These observations have suggested (4) that perhaps such retroviral activity may be obligatory late steps in the carcinogenic process with many chemicals, radiations, and other viruses. The existence of normal genes, so called "oncogenes." in virtually all cells and their close similarity to the viral genes, makes this an attractive hypothesis (2). However, the available data are not by themselves convincing except in rare instances (1, 3).
EVIDENCE FOR PRECANCEROUS LESIONS
As discussed previously (5, 9, lo), the frequent occurrence of lesion prior to the appearance of cancer could reflect parallel phenomenon, not necessarily sequential. Given the highly reactive nature of ultimate carcinogens and of radiations, it is most probable that chemical carcinogens and radiations induce a whole array of tissue and cellular changes, only a proportion (a tiny minority?) of which have any direct relevance to cancer development. Since the immediate fate of initiated cells is largely a reflection of the local environment, as influenced by promoting agents (6, 8, 9), two groups of initial changes can be recognized: those that relate to the initiation events in the few rare cells (9) and those that alter the surrounding cells to influence the selective growth of the few initiated cells. Thus, the common Occurrence of reproducible focal proliferative changes throughout the carcinogenic process well before the appearance of any key properties of cancer is not in and of itself proof for precancerous steps in the development of cancer.
In humans, there is abundant evidence for the close statistical association between certain putative precursor lesions, such as atypical hyperplasias, carcinoma in situ, focal proliferations in many sites (liver, skin, urinary bladder, colon, brain, thyroid, bronchus, etc.), and the subsequent occurrence of malignant neoplasia. More convincing is the evidence that new populations, resembling unequivocal carcinomas, are seen to arise in many putative precancerous lesions such as polyps and nodules in solid organs.
These well-known observations in humans are in turn supported by even more convincing evidence in experimental systems in the liver and skin. In the liver of the rat, persistent hepatocyte nodules (7, 8) are clearly precancerous as evidenced by (a) the occurrence of metastasizing cancer inside nodules with no cancer elsewhere in the liver (8), (b) the common occurrence of new noncancerous "nodules in nodules" before cancer appears (7, 12), and (c) their high rate of evolution to cancer when transplanted to the spleen (11). In the skin, persistent papillomas are a known site of origin for squamous cell carcinomas.
Thus, clearly precancerous lesions, i.e., focal lesions in which cancer arises, are seen in several systems of cancer development in humans and in experimental animals. Whether such lesions are obligatory or exclusive has not been established and it is doubtful whether it can ever be answered, at least from a current perspective. However, the intensive study of the sequence from precancerous to cancer would seem to be an analyzable approach to understanding how cancer develops in experimental animals and then to test any hypothesis thereby formulated in systems in humans. and Bishop JM (1984 DR. APPLETON: Now in that case, it doesn't seem to fit into any of the three schemes, so the question that I have is-can chronic hyperplasia or chronic irritation or chronic disruption of homeostasis lead to potential cancer development?
DR. FARBER: Yes, it doesn't fit. You know, we were brought up, perhaps you weren't, but I was brought up with the notion that the old Virchow idea was nonsense. Virchow proposed around the 1880's that chronic irritation led to cancer. Everybody accepted it, and then, it was ignored. I don't think so. My own view is that this is an important component in initiation. I would agree with you. I think that one has to start to look at the chronic irritation as a possibility. Now, you can't say yes, but you should begin to explore it.
DR. SWARM: One more question. DR. CLAYSON: Dr. Farber, I think you told us in the course of your talk that practically every one of our scientific endeavors is not going to help us very much. You referred to hyperplasia, DNA adduct, oncogenes, viruses, the lot, and you have run each of them down, possibly rightly. The question I would like to put to you is this-Is this simply a matter that we haven't turned up the right stone in our hunt for cancer or is it, more difficultly, that we haven't learned how to integrate the patterns? DR. FARBER: I'm not ignoring any of these, David. Each of them is very important in their own way, but none of them explain cancer. I think that the second point is the key. Cancer is some kind of complex network of interacting factors, and therefore I think we run a risk in trying to identify one factor, except in a few instances. You know this. An individual who works in, let's say, synthesis of benzidine and is covered from top to bottom in benzidine, 8 hours a day for 20 years, will get cancer of the urinary bladder. Under those conditions perhaps the chemical is playing the major or only role.
I think most of the time, and certainly in humans, we're dealing with networks. I think we have to be aware of all of the different factors, and perhaps then take into account some kind of balancing of these things. I didn't mean to be negative. I believe in adducts. I believe in all of these things, with moderation. DR. LEADER: The general idea of reduced nutrition that has come out of experimental animals and now appears, epidemiologically in people, to have some relationship perhaps to the general incidence of cancer. Do you have a comment on that whole idea? We're looking at lipids or whatever, but it may be something else.
DR. FARBER: Well, you know the old idea,
under-nutrition, you live longer and you're healthier. Yes, I think it is true. I think it is the old story that we're dealing not with an agent but with how a living organism reacts when you perturb it. The reaction is very much dependent upon the mediator. We know already. if you take an animal or even people (people too, during the war) and you under-expose them to certain nutritional conditions they react totally differently. They I get diseases which we don't see normally.
There is no doubt that nutrition is probably the single most important factor in creating the environment that's for or against cancer. I agree there. On the other hand, what about all of the other factors? What about fat and lipid? The epidemiologists tell us it is there, so I have to believe them. Certainly there are lots of geographic differences-no question, but what's the basis for them? No one yet has found out. So, maybe we're not even aware of all the subtleties that these dietary modulations do. Maybe they're affecting cell proliferation in a way which we don't understand. I think that is why we have to go back and develop much more basic understanding before we're in a position to make generalizations.
DR. SWARM: I think one of the things-that
is eminently clear to us as we look at cancer is that we profit by people's experience. Sometimes, people talk about this as bias. I prefer to talk about it as experience.
